Recent

% | $
Quotes you view appear here for quick access.

NuPathe Inc. Message Board

  • corsovene corsovene Mar 22, 2013 3:11 PM Flag

    Glaxo owns 8.91% of NuPathe :LOOK at SEC: Date 2/12/13

    13G

    CUSIP No. 67059M100

    1.
    Names of Reporting Persons.

    GlaxoSmithKline plc
    2.
    Check the Appropriate Box if a Member of a Group
    (a) ¨ (b) ¨

    3.
    SEC Use Only

    4.
    Citizenship or Place of Organization

    England and Wales
    Number of Shares
    Beneficially
    Owned by
    Each Reporting Person
    With:
    5.
    Sole Voting Power

    4,166,846
    6.
    Shared Voting Power

    0
    7.
    Sole Dispositive Power

    4,166,846
    8.
    Shared Dispositive Power

    0
    9.
    Aggregate Amount Beneficially Owned by Each Reporting Person

    4,166,846
    10.
    Check if the Aggregate Amount in Row (9) Excludes Certain Shares ¨

    11.
    Percent of Class Represented by Amount in Row (9)

    8.91%
    12.
    Type of Reporting Person

    CO
    13G
    CUSIP No. 67059M100

    ITEM 1.
    (a) Name of Issuer:
    NuPathe Inc.
    (b) Address of Issuer’s Principal Executive Offices:
    227 Washington Street
    Suite 200
    Conshohocken, PA 19428
    ITEM 2.
    (a) Name of Person Filing:
    GlaxoSmithKline plc
    (b) Address of Principal Business Office, or if None, Residence:
    980 Great West Road
    Brentford
    Middlesex
    TW8 9GS ENGLAND
    (c) Citizenship:
    England and Wales
    (d) Title of Class of Securities:
    Common Stock, par value $0.001 per share
    (e) CUSIP Number:
    67059M100

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PATH
4.250.00(0.00%)Feb 21 4:00 PMEST